Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy
| Status: | Recruiting |
|---|---|
| Conditions: | Other Indications, Neurology, Gastrointestinal, Epilepsy |
| Therapuetic Areas: | Gastroenterology, Neurology, Other |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 8/11/2018 |
| Start Date: | August 10, 2015 |
| End Date: | August 10, 2020 |
| Contact: | Sukumar Deeptha, PhD |
| Email: | deeptha.sukumar@drexel.edu |
| Phone: | 267 359 5854 |
The objective of this study is to determine the role of magnesium on bone and vitamin D
metabolism in patients receiving anti-epileptic medications.
metabolism in patients receiving anti-epileptic medications.
Inclusion Criteria:
- Individuals receiving anti-epileptic drugs as a treatment for epilepsy
Exclusion Criteria:
- Individuals who are pregnant or breastfeeding, receiving cancer treatments, have liver
or kidney diseases, autoimmune diseases, or other diseases that may interfere with
vitamin D and magnesium metabolism.
We found this trial at
2
sites
1601 Cherry Street
Philadelphia, Pennsylvania 19102
Philadelphia, Pennsylvania 19102
Phone: 267-359-5854
Click here to add this to my saved trials
Click here to add this to my saved trials